TRVI · Trevi Therapeutics, Inc. · Proposed Sales
$13.29
-0.44 (-3.17%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$2.05B
Shares
142.48M
Volume · Oct 6
1.35M
Avg daily vol (3M)
1.92M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-09-15 | MICHAEL HEFFERNAN | Director | 39,473 | 2026-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-07 | Delfini Lisa | Officer | 108,650 | 2025-10-07 | Stifel Nicolaus & Company Inc |
| 2025-10-03 | Delfini Lisa | Officer | 40,000 | 2025-10-03 | Stifel Nicolaus & Company Inc |
| 2025-08-27 | Delfini Lisa | Officer | 312,855 | 2025-08-27 | Stifel Nicolaus & Company Inc |
| 2025-03-21 | GOOD JENNIFER L | Officer | 5,263 | 2025-03-21 | Stifel Nicolaus & Company Inc |
| 2025-03-10 | Simon Farrell | Officer | 81,313 | 2025-03-10 | Stifel Nicolaus & Company Inc |
| 2024-09-03 | GOOD JENNIFER L | Officer | 61,180 | 2024-09-03 | Stifel Nicolaus & Company Inc. |
| 2024-08-27 | Meeker David P | Officer | 4,555 | 2024-08-27 | Stifel Nicolaus & Company Inc. |
| 2024-08-15 | SCIASCIA THOMAS | Officer | 48,001 | 2024-08-15 | Stifel Nicolaus & Company Inc. |
| 2024-05-29 | SCIASCIA THOMAS | Officer | 53,368 | 2024-05-29 | Stifel Nicolaus & Company Inc. |
| 2023-09-11 | Delfini Lisa | Officer | 1,600 | 2023-09-11 | Stifel Nicolaus & Company, Inc |
| 2023-06-12 | Delfini Lisa | Officer | 1,615 | 2023-06-12 | Stifel Nicolaus & Company, Inc |
| 2023-04-11 | Delfini Lisa | Officer | 1,900 | 2023-04-11 | Stifel Nicolaus & Company, Inc |
Showing 1–13 of 13 filings